Abzhandadze, Tamar
Hoang, Minh Tuan
Bao, Xinqi
Åkerman, Madeleine
Norgren, Jakob
García Pascual, Belén
Mo, Minjia
Eriksdotter, Maria
Xu, Hong
Garcia-Ptacek, Sara
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 8 January 2026
Accepted: 30 June 2026
First Online: 11 July 2026
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (2024–08463-01). Data were extracted and anonymized from electronic records. The Swedish Ethical Review Authority, in accordance with the Personal Data Act (Swedish law No. SFS 1998:204), waived patient consent for this study. Participants were informed about registration in SveDem and their right to deny participation (opt-out consent). The NACC database collected data with written informed consent at the contributing centers; all analyses used pseudonymized data.
: Not applicable.
: ME has served as speaker and/or consultant on dementia at sporadic advisory board meetings for Biogen, Bioarctic, Roche, Eli Lilly, and NovoNordisk. All other authors declare no competing interests.